...
机译:透析1B慢性丙型肝炎透析患者的透析患者的疗效和安全性的疗效和安全性
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
Core Research Facilities for Basic ScienceJikei University School of MedicineTokyo Japan;
Division of Gastroenterology and HepatologyJapanese Red Cross Saitama HospitalSaitama Japan;
Department of Internal Medicine Division of Hepatology and GastroenterologyTokyo Medical;
Department of Internal Medicine Division of GastroenterologyMito Saiseikai General HospitalIbaraki;
Department of Internal Medicine Division of Gastroenterology and HepatologyOtakanomori;
Department of Internal Medicine Division of Gastroenterology and HepatologySeirei Sakura Citizen;
Department of Internal Medicine Division of Gastroenterology and HepatologyShinmatsudo Central;
Department of Internal Medicine Division of Gastroenterology and HepatologyShinmatsudo Central;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
Department of Internal Medicine Division of GastroenterologyKikkoman General HospitalChiba Japan;
Department of Internal Medicine Division of Gastroenterology and HepatologyTokyo Metropolitan;
Department of Internal Medicine Division of Gastroenterology and HepatologyTokyo Metropolitan;
Department of Internal Medicine Division of Hepatology and GastroenterologyTokyo Medical;
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
chronic hepatitis C; dialysis; end‐stage renal disease; genotype 1b; ombitasvir/paritaprevir/ritonavir;
机译:透析1B慢性丙型肝炎透析患者的透析患者的疗效和安全性的疗效和安全性
机译:ombatasvir / ritonavir / paritaprevir组合治疗对基因型1b慢性乙型肝炎患者的疗效和安全性与慢性肾病复杂的疗效和安全性
机译:Ombitasvir,Paritaprevir和Ritonavir在有和没有肝硬化的基因型1b慢性丙型肝炎病毒感染患者的开放标签研究中的功效和安全性
机译:临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:Ombitasvir / Paritaprevir / Ritonavir和Dasabuvir联合或不联合利巴韦林在接受阿片类药物替代治疗的慢性丙型肝炎病毒基因型1感染患者中的疗效和安全性:对12项临床试验的事后分析
机译:Ombitasvir,Paritaprevir和Ritonavir在有和没有肝硬化的基因型1b慢性丙型肝炎病毒感染患者的开放标签研究中的功效和安全性